First Sponsor (ADN) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
29 Oct, 2026Executive summary
1H2025 attributable profit rose 59.2% YoY to S$19.0m, mainly on higher associate and JV contributions, including Time Zone and Egret Bay handovers and NSI’s contribution.
Revenue declined 11.0% YoY to S$153.9m; profit for the period rose to S$26.7m from S$14.9m, supported by higher associate and JV earnings and lower tax expense.
PRC development pre-sales remained subdued, with Central Mansion targeted for completion in 2025; a 1.1 Singapore cent per-share FY2025 interim tax-exempt dividend was approved, unchanged YoY.
Financial highlights
Revenue fell 11.0% to S$153.9m, gross profit declined 15.5% to S$60.7m and operating profit fell to S$28.3m from S$47.1m; PBT increased 2.9% to S$33.4m.
Attributable profit rose 59.2% to S$18.978m from S$11.924m; basic and diluted EPS were 1.16 cents, up 8.4% and 26.1%, respectively.
Share of after-tax associate and JV profit increased to S$27.3m from S$6.5m, including S$9.3m from NSI; PBT included S$3.7m higher disposal gains and S$2.9m higher property-holding gross profit.
Prior-year PBT included a S$10.2m fair-value gain absent in 1H2025; other expenses were S$4.8m versus other income of S$8.9m, including FX losses and fair-value gains on derivatives and equity securities.
Gross margin was 39.4% versus 41.5%; net finance costs increased 5.4% to S$22.3m.
Outlook and guidance
Central Mansion is targeted for completion in 2025; PRC asset exposure is expected to decline gradually as projects complete and EU and Australian activities progress.
Dreeftoren office and residential completion are targeted for 4Q2025 and 4Q2026, respectively; Sydney House completion is targeted for 3Q2027.
Meerparc redevelopment is estimated to begin in 1H2027 after building-permit approval, with urban-planning procedures being prepared for 1H2026; European redevelopments and renovations are expected to enhance recurring income over time.
Management considers its currency-hedging strategy appropriate and will monitor exposures; a strong balance sheet and unutilised committed credit facilities support resilience and pursuit of opportunities.
Latest events from First Sponsor
- European income grew as PRC presales stayed weak; NSI profit and S$244m rights proceeds bolstered 3Q.ADN
Q3 2024 TU - FY2023 profit fell 90.5% as European property income and equity proceeds supported resilience.ADN
H2 2023 - European income and hotel earnings improved as PRC property demand stayed weak.ADN
Q1 2024 TU - Revenue rose 27.2% and profit 12.4%, despite weak PRC pre-sales and higher financing costs.ADN
H1 2024 - NSI earnings lifted FY2024 profit despite PRC weakness and impairment charges.ADN
H2 2024 - Weak PRC presales contrast with stable European income and progress on loan recovery.ADN
Q1 2025 - Loan recovery and refinancing bolster flexibility as PRC sales stay weak and European income edges higher.ADN
Q3 2025 TU - Derivative losses drove FY2025 reported loss despite adjusted profit and stronger European hotels.ADN
H2 2025 - H1 attributable loss reached S$92.8m as derivatives and Humen impairment offset European NOI growth.ADN
H1 2026